Abbott Laboratories (ABT) entered a merger agreement on November 20, 2025, to acquire Exact Sciences (EXAS) in a deal valued at $23 billion.
Abbott will acquire all outstanding shares of Exact Sciences for $105 per common share in cash, representing a premium of 21.84% from the stock’s last close.
Exact Sciences is a cancer diagnostics company that develops and provides screening and genetic testing products, including Cologuard and Oncotype DX, to help detect cancer.
Abbott is a healthcare company that develops diagnostics, medical devices, nutrition products, and branded generic medicines to help people live healthier lives.
A day ago, Bloomberg reported that Abbott was nearing a potential acquisition of Exact Sciences. The stock was trading at $69.68 before the report came out.
The closing is expected in the second quarter of 2026.
Exact Sciences will keep its operations in Madison, Wisconsin, and CEO Kevin Conroy will continue with the company in an advisory capacity.
Centerview Partners and XMS Capital Partners are helping Exact Sciences with financial advice, and the law firm Skadden, Arps, Slate, Meagher & Flom is handling their legal work. Morgan Stanley is giving financial advice to Abbott, and the law firm Wachtell, Lipton, Rosen & Katz is providing it with legal support.
For a more comprehensive understanding of this significant M&A transaction, please visit the Deal Metrics page here:
Deal Metrics for the acquisition of Exact Sciences Corporation (EXAS) by Abbott Laboratories (ABT)
The Deal Metrics page for each merger or acquisition includes a spread history chart of the merger from announcement through completion or failure, every event as the merger progresses through regulatory approvals, shareholder votes, news, SEC filings, deal updates, and more.
Disclaimer: It is advised to conduct your own due diligence before buying or selling any securities mentioned in this article. The completeness or accuracy of the content or data provided in this article is not warranted.
Editor’s Note: Baranjot Kaur contributed to this article